Business Context and Reporting Period
Company: Cal-Maine Foods, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 11, 2025
Reporting Period: Specific event date (August 11, 2025)
This filing reports significant corporate governance changes and executive appointments effective August 11, 2025. The Company is incorporated in Delaware and trades on the NASDAQ Global Select Market under the symbol "CALM".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on personnel and governance matters.
Material Changes and Corporate Actions
- Board Expansion: The Board of Directors increased its size from seven to eight members.
- Director Appointment: Melanie Boulden was appointed as an independent Class I director, serving until the 2025 annual meeting of stockholders.
- Committee Assignments: Effective September 1, 2025, Ms. Boulden will join the Compensation, Audit, and Nominating and Corporate Governance Committees.
- Executive Appointment: Keira Lombardo was appointed as the Company's first Chief Strategy Officer, effective immediately.
Compensation and Outlook
Director Compensation:
- Annual Fee: $45,000, paid in quarterly installments in advance.
- Equity Grant: On August 11, 2025, Ms. Boulden received 938 restricted stock awards (RSAs) under the 2012 Omnibus Long-Term Incentive Plan.
- Vesting Schedule: The RSAs vest 100% on January 14, 2028.
Management Commentary:
- Ms. Lombardo is described as a seasoned food and agriculture executive with over two decades of experience leading transformation and growth.
- The Board determined Ms. Boulden is independent under Nasdaq Listing Standards and meets all requirements for her committee assignments.
Risks and Contingencies: The filing does not disclose new material risks or contingencies beyond standard governance disclosures.
Investor Verification Checklist
- Verify the independence status of Melanie Boulden against Nasdaq Listing Standards.
- Review the full text of the press releases (Exhibits 99.1 and 99.2) for additional biographical details on the new appointees.
- Confirm the vesting terms of the 938 RSAs granted to Ms. Boulden in the Company's Long-Term Incentive Plan.
- Monitor future filings for the formal election of Ms. Boulden at the 2025 annual meeting of stockholders.